Skip to main content
. 2023 Aug 31;59(9):1584. doi: 10.3390/medicina59091584
ASD Autism spectrum disorder
CAM Complementary and alternative medicine
ROS Reactive oxygen species
PDDs Pervasive developmental disorders
AAs Amino acids
AS Asperger’s syndrome
NMDA N-methyl D-aspartate
NO Nitric oxide
BBB blood–brain barrier
MDA Malondialdehyde
DHA Docosahexaenoic acid
ALA Alpha-linolenic acid
EPA Eicosapentaenoic acid
NF-κB Nuclear factor kappa B
PI3K Phosphatidylinositol 3-Kinase
RCTs Randomized controlled trials
BDNF Brain-derived neurotrophic factor
COX Cyclooxygenase
PPARs Peroxisome proliferator-activated receptors
eNOS Endothelial nitric oxide synthase
SIRT1 Sirtuin (silent mating type information regulation homolog 1)
AMPK AMP-activated protein kinase
RSV Resveratrol
VPA Valproic acid
PVC Parvalbumin
PPA Propionic acid
MMP-9 Matrix metalloproteinase-9
SD Schizotypal disorder
NAR Naringenin
VLDL Very low-density lipoproteins
MCAO Middle cerebral artery occlusion
SOCS3 Suppressor of cytokine signaling 3
NRF2 Nuclear factor erythroid 2–related factor 2
CGA Clinical Global Assessment
ABC Autism Behavior Checklist
SRS Social Responsiveness Scale
GSH-Px Glutathione peroxidase
SOD Superoxide dismutase
MPO Myeloperoxidase
ETC Electron transport chain
GI Gastrointestinal
RDBPC Randomized Double Blind Placebo Control
PedPRM Pediatric-appropriate prolonged-release melatonin
RRBs Restricted and repetitive behaviors
IMFAR International Meeting for Autism Research
SRS Social Responsiveness Scale
CBD Cannabidiol
THC Tetrahydrocannabinol
GABAA Gamma-Aminobutyric Acid-A
AEA N-arachidonoylethanolamine (anandamide)
ECS Endocannabinoid system
CNS Central nervous system
DAGL Diacylglycerol lipase
2-AG 2-arachidonoylglycerol
FXS Fragile X Syndrome
CBDV Cannabidavarin
ADAMS Anxiety, Depression, and Mood Scale
FDA Food and Drug Administration
SCFAs Short-chain fatty acids
Mg Magnesium
PD Parkinson’s disease